Shandong Jincheng Pharmaceutical Group Co., Ltd
300233.SZ · SHZ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CN¥7 | CN¥7 | CN¥8 | CN¥5 |
| - Cash | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| + Debt | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Enterprise Value | CN¥7 | CN¥6 | CN¥7 | CN¥4 |
| Revenue | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| % Growth | -10.4% | -11.6% | -15.9% | – |
| Gross Profit | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 36.5% | 38.3% | 34.2% | 40.1% |
| EBITDA | -CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | -1.1% | 2% | 7.4% | 18.1% |
| Net Income | -CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | -2.1% | 1.3% | 4.9% | 5.3% |
| EPS Diluted | -0.031 | 0.021 | 0.09 | 0.12 |
| % Growth | -245.3% | -76.2% | -25% | – |
| Operating Cash Flow | CN¥0 | CN¥0 | -CN¥0 | CN¥0 |
| Capital Expenditures | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| Free Cash Flow | CN¥0 | CN¥0 | -CN¥0 | CN¥0 |